Jihua Chunqiu has intensified the market promotion of COVID-19 detection box

        In June 9, 2021, Jihua Chunqiu(International )Trading Co., Ltd. signed an exclusive agency agreement about COVID-19 detection box with Innovation Biotechnology Co. ,Ltd. Jiangsu, which is solely responsible for the market development, sales and promotional activities of the following products.         

        New coronavirus (SARS-CoV-2) antigen detection kit (immunochromatography)

        Novel Coronavirus（SARS-CoV-2）Neutralizing Antibody Test Kit (Immunochromatography)

        COVID-19 Neutralizing Antibody Rapid Testing Kit (Colloidal Gold) 

        USE：

        The novel coronavirus antigen test is a lateral flow immunoassay method for the qualitative detection of SARS-CoV-2 nucleocapsid protein (NP) antigens in the nasopharynx and oropharynx of individuals suspected of COVID-19.

        The antigen detection kit is different from the antibody detection kit, which uses the principle of colloidal gold immunochromatography to qualitatively detect the new coronavirus (COVID-19) Np antigen in human nasal swabs. 

        This technology provides a simple workflow, short turnaround time and rapid diagnosis for suspected COVID-19 patients.

        Nucleic acid testing is a testing method that consumes manpower and time. It has high requirements for testing equipment, environment and testing personnel, and can only be carried out in professional institutions; while the detection rate of antibody testing in the two weeks before infection is extremely low, it is not applicable Early detection of infection. 

        The reliability and detection rate of antigen detection is high, and it can be completed at the site of sample collection. It only takes 15-20 minutes to obtain the test results. The detection method is faster, cheaper and simpler.